Merchant Nishant, David Calvin S, Cunningham Steven C
Department of Surgery, Saint Agnes Hospital, 900 Caton Avenue, Mailbox #207, Baltimore, MD 21229, USA.
Int J Hepatol. 2011;2011:142085. doi: 10.4061/2011/142085. Epub 2011 Apr 27.
The optimal surgical treatment of hepatocellular carcinoma on well-compensated cirrhosis is controversial. Advocates of liver transplantation cite better long-term survival, lower risk of recurrence, and the ability of transplantation to treat both the HCC and the underlying liver cirrhosis. Transplantation, however, is not universally available to all appropriate-risk candidates because of a lack of sufficient organ donors and in addition suffers from the disadvantages of requiring a more complex pre- and postoperative management associated with risks of inaccessibility, noncompliance, and late complications. Resection, by contrast, is much more easily and widely available, avoids many of those risks, is by many accounts as effective at achieving similar long-term survival, and still allows for safe, subsequent liver transplantation in cases of recurrence. Here, arguments are made in favor of resection being easier, safer, simpler, and comparably effective in the treatment of HCC relative to transplantation, and therefore being the optimal initial treatment in cases of hepatocellular carcinoma on well-compensated cirrhosis.
对于代偿良好的肝硬化患者,肝细胞癌的最佳手术治疗方法存在争议。肝移植的支持者认为,肝移植具有更好的长期生存率、更低的复发风险,并且能够同时治疗肝细胞癌和潜在的肝硬化。然而,由于缺乏足够的器官供体,并非所有具有适当风险的候选者都能普遍接受移植,此外,肝移植还存在缺点,即需要更复杂的术前和术后管理,存在难以获得、患者不依从以及晚期并发症等风险。相比之下,肝切除术更容易实施且应用更广泛,可避免许多上述风险,许多人认为肝切除术在实现相似的长期生存率方面同样有效,并且在复发情况下仍允许进行安全的后续肝移植。在此,有观点认为,相对于肝移植,肝切除术在治疗肝细胞癌方面更容易、更安全、更简单且效果相当,因此是代偿良好的肝硬化患者肝细胞癌的最佳初始治疗方法。